The United Kingdom took in 30,062 kg of medical cannabis flower during 2025. Of that, 17,067 kg shipped directly from Canada. The Canadian figure a year earlier was 2,578 kg. British prescribing did not grow sixfold in twelve months. What changed is that Canadian producers stopped routing product through Spanish and Portuguese processors and started shipping in bulk on their own paperwork.
UK cannabis import requirements rest on five separate authorisations, held by two parties in two countries. The UK importer needs a Home Office controlled drug licence, a Manufacturer's (Specials) Licence, an accepted MHRA notification of intent, and a shipment-specific import licence. The Canadian Licensed Producer needs an export permit from Health Canada, issued against that import licence. Four of the five sit on the British side of the deal. Your UK timeline is therefore decided mostly by a partner you do not control.
If you already ship to Germany, very little of that experience transfers. The instruments have different names, different issuers and different clocks. Assuming European export practice carries across the Channel is the most expensive mistake in this market.
Where UK import demand stands in 2026
Home Office figures released under freedom of information in April 2026 put total UK imports of dried cannabis flower at 30,062 kg for 2025. The 2024 figure was 14,992 kg. That makes 2025 the largest year the market has recorded. The dataset covers flos preparations classified as unlicensed specials, so extracts and active pharmaceutical ingredients sit outside it. Shipments from the Crown Dependencies are excluded too.
The quarterly split shows the shape of the year. Imports ran at 5,285 kg in Q1 and 11,810 kg in Q4, a rise of 123 percent across four quarters. Direct Canadian shipments accounted for 7,839 kg of that Q4 figure alone. Hold the Q4 run rate steady and 2026 lands near 47,000 kg. One quarter of inventory building is a thin basis for a full-year forecast, so treat that number as a ceiling rather than a plan.
| Shipped from | 2024 | 2025 | Direction |
|---|---|---|---|
| Canada, direct | 2,578 kg | 17,067 kg | Up more than sixfold |
| Portugal | 2,466 kg | 3,971 kg | Up |
| South Africa | 421 kg | 1,345 kg | Up |
| Germany | 1,963 kg | 1,404 kg | Down |
What the Spanish decline actually tells you
Spain shipped 3,417 kg in 2025, or 11.4 percent of the total. Its quarters ran 1,591 kg, then 1,176 kg, then 490 kg, then 161 kg. A processing hub does not shed 90 percent of its volume inside a year because demand fell. It sheds volume because the product it used to handle now travels a shorter route. Fourteen countries shipped flower to the UK in 2025, up from eleven the year before. Switzerland, Czechia and Greece each appeared for the first time.
A caveat on the baseline
Comparisons against 2023 need care. The raw 2023 total looks like 26,973 kg. More than 20,113 kg of that arrived from Finland in two near-identical batches during the first half of the year, after which Finland vanished from the data and never returned. Finland does not export medical cannabis. Strip those consignments out and the adjusted 2023 baseline falls to roughly 6,860 kg. On that corrected figure, the UK has doubled in volume two years running, which is a cleaner story than the raw numbers tell.
Two more caveats matter for planning. The Home Office records the country a shipment was processed and exported from, not the country where the plant was grown. Canada's true share of UK supply is therefore higher than 17,067 kg, because Canadian-origin flower still moves under Portuguese and Spanish export paperwork. The 2025 figures also stayed provisional until the INCB annual returns process closed on 30 June 2026. For the wider picture of second-tier destinations opening alongside the UK, our review of emerging cannabis import markets sets out the screening logic.
What the specials route demands from a Canadian producer
An unlicensed medicines channel constrains your commercial options, not just your filing obligations. A special exists to meet the clinical need of a named patient, on the order of a specialist prescriber. Cost, convenience and operational preference are not lawful reasons to use one. The product cannot be marketed or promoted in the UK. If your commercial plan assumes brand building at pharmacy level, the specials framework will not carry it.
Who your customer actually is
The prescription originates with a doctor on the General Medical Council Specialist Register, written on a controlled drug prescription form. Procurement sits with pharmacies and licensed wholesalers, supplied in turn by the Specialist Importer. Your commercial counterparty is that importer or a licensed wholesaler behind it, never the clinic and never the patient. Market trackers put the average UK pharmacy price for medical cannabis flower at about GBP 6.95 per gram as of December 2025, which is the number your buyer is working backwards from when they price a wholesale block.
The quality evidence a UK importer will ask for
Product has to come from a manufacturing site holding a GMP certificate recognised by the UK licensing authority. In practice that means EU-GMP or an equivalent the MHRA accepts. It is the reason Canadian producers built certified domestic facilities rather than continuing to pay an Iberian processor to put its name on the export paperwork. The importer will also want a valid certificate of analysis for every batch. That document sits on its own supply chain checklist and is inspectable, so the panel behind it has to hold up. Our comparison of export testing requirements across four markets shows where a Canadian panel already meets a European reviewer's expectations and where it does not.
Batch release is worth resolving before you agree terms rather than after. Our guide to QP batch release for Canadian LPs sets out who signs, what they sign against, and where Canadian testing data does and does not satisfy a European reviewer.
Four documents, one product name
Keep the product description identical across the MHRA notification, the Home Office import licence, the Canadian export permit and the batch certificate of analysis. A cultivar that ships domestically as one SKU, then appears on a UK notification under a slightly different name, gives a reviewer a reason to pause the file. Fixing that at the outset costs an afternoon. Fixing it mid-shipment costs a quarter. The same discipline applies to how the consignment is described for customs, which our guide to HS codes and customs classification covers in detail.
Expect the consignment to sit still on arrival. UK customs checks run first. The product then goes into quarantine at the importer's warehouse until routine checks clear, so it is not saleable stock on the day it lands. Records must be retained for at least five years and produced for MHRA inspection on request. Your COAs and traceability files have a British half-life long after the invoice is settled.
Where the UK timeline breaks, and how to plan around it
Three clocks run at once, and they are not synchronised. The MHRA notification has to be filed at least 28 days before the intended import date, and the agency may object within 28 days of acknowledging it. The Home Office import licence takes weeks to obtain, covers a single shipment, and is normally valid for around three months. A Schedule 2 controlled drug prescription is valid for only 28 days from the date the prescriber signs it.
The mismatch is obvious once you lay it out. Clinical demand arrives on a 28-day cycle. Supply moves on a multi-month one. No importer can buy against individual prescriptions under those conditions. That is exactly why the 2025 quarterly data looks the way it does, with large wholesale blocks and year-end inventory building rather than steady clinic-led draw.
How a first consignment actually sequences
Work backwards from the landing date. The importer files its MHRA notification and its Home Office import licence application in parallel, because MHRA guidance permits both to run at the same time. That MHRA window closes at day 28 at the earliest, while the Home Office licence lands on its own schedule, usually later. Only then does the licence copy reach you, and only then can you file your Cannabis Act export permit application. Sequencing those steps one after another instead of in parallel adds a month for no reason.
Four things to fix before you commit volume
- Verify that the importer's licence class covers direct third-country supply, before you quote pricing or reserve inventory.
- Agree the exact product name and specification early, so the MHRA notification and your export permit describe the same thing.
- Treat the three-month import licence validity as your shipping window, not as a comfortable buffer.
- Hold the import licence copy in hand before you file your export permit application, never after.
The wider point is that a German playbook will not survive contact with this market. Germany's route attaches to a narcotics import permit issued by the Bundesopiumstelle. The UK route attaches to a specials notification plus a per-shipment controlled drug licence, under a medicines regulator that can object on quality grounds inside its own 28-day window. Same product, same origin, different machinery. Any LP running a single European export process across every destination will find the UK is where it breaks.
AlphaLeaf is a Montreal-based Health Canada Licensed Producer growing indoor, hand-trimmed flower from refined genetics. We hold export authorisation under the Cannabis Act. We also maintain the ISO/IEC 17025 batch testing records and lot-level traceability a UK Specialist Importer needs to support its own notification, its supply chain checklist and an MHRA inspection.
If you are a UK importer building direct Canadian supply for 2026, or a Canadian LP weighing Britain against a fourth German partner, talk to our export team about batch availability, specification and documentation. Our certifications and testing standards set out what we can evidence today.
Frequently Asked Questions
Can a Canadian Licensed Producer export cannabis flower to the UK?
Yes. Canadian producers shipped 17,067 kg of dried flower directly to the UK in 2025. The route requires a UK importer holding the correct Home Office and MHRA authorisations, plus a Health Canada export permit issued against that importer's shipment-specific import licence.
What licences does a UK importer of Canadian cannabis need?
Four. A Home Office controlled drug licence covering its site and activities, a Manufacturer's (Specials) Licence because Canada is a third country, an accepted MHRA notification of intent to import, and a Home Office import licence for each individual shipment.
How far in advance must the MHRA notification be filed?
At least 28 days before the intended import date. The MHRA can raise an objection within 28 days of acknowledging the notification, which blocks the import. It can be submitted in parallel with the Home Office import licence application rather than after it.
Is a UK cannabis import licence valid for more than one shipment?
No. A separate Home Office import licence is required for every consignment, and each is normally valid for around three months. Building a supply agreement around a single licence is not possible.
Does cannabis flower sent to the UK have to be EU-GMP certified?
It must be manufactured at a site holding a GMP certificate recognised by the UK licensing authority. EU-GMP is the standard route to meeting that requirement, which is why Canadian producers now ship from certified domestic facilities instead of routing product through European processors.
What is a cannabis special in the UK?
A special is an unlicensed medicine supplied under Regulation 167 of the Human Medicines Regulations 2012 to meet the clinical need of an individual patient. Nearly all cannabis flower prescribed in Britain is supplied this way, which is why it cannot be marketed or promoted.
How large is the UK medical cannabis flower market?
The UK imported 30,062 kg of dried flower in 2025, up from 14,992 kg in 2024, according to Home Office data. If the fourth-quarter run rate of 11,810 kg holds, 2026 volumes would land near 47,000 kg.
